Reducing Unnecessary Screening in Lynch-Like Syndrome with Tumor Sequencing

Session:
#64
Date:
Sunday, Oct 14, 2018 5:30pm – 7:00pm
Conference:
CGA-IGC 2018
Authors:
Amber Gemmell, Andrea Forman, Brigette Tippin Davis, Holly Laduca, Kory Jasperson, Kyle Allen, Leigha Senter, Sara Pirzadeh-Miller, Virginia Speare
  • A simulated case based survey assessed the use of tumor sequencing data in making recommendations for colon and endometrial cancer screening/prevention in suspected Lynch syndrome.
  • Providers often recommend increased screening procedures based on the detection of mismatch repair deficiency by IHC staining, even when no germline MMR mutation has been identified.
  • Knowledge of biallelic somatic mutations in a MMR gene (detected by tumor sequencing) helps to rule out Lynch syndrome and reduces the need for costly high-risk screening and risk reduction procedures.